Video Library

Ready to get your business model up on the floor for investors and clients? The best biotech startup or medical device pitch decks have precise and clear problem statements and definitions. In this video, I provide examples of pitch decks that capture the specificity needed to set your problem statement apart. A clear problem statement not only improves your pitch deck, it shows the business model for your innovation is reasonable, well thought-out and ready for investment. Check out my other videos for more content like this! WEBSITE: www.ogadvisors.us YOUTUBE CHANNEL: @OGAdvisors CONTACT ME: https://www.linkedin.com/in/oganel/ Hastags: #patient #startup #statement #pitchdeck #biotech #businessmodel #products #partnership #sowhat #example #biotech #medicaldevice

One of the first questions on any drug developer's mind is how much it is worth...followed by how much could they hope to capture from it. The Asset Valuation Tool quickly provides a ballpark of what the asset could be worth, and runs scenarios of licensing deals. It provides a common framework for the inventor and the development partnerto visualize the different scenarios and value points. If you're interested in taking a look, you are welcome to comment or DM me, and I will send you the link and password to try it out!

Data room prep may sound like a chore, but early and thorough planning can set your company apart, bolster deal momentum, and create a sense of urgency. In this segment I discuss the pros of getting your data room ready before you need it, and share my favorite data room platform your data room prepare now dataogadvisors data "Prepare Your Data Room Now" serves as a strategic imperative championed by OGAdvisors, embodying their proactive and meticulous approach to financial management and advisory services. This directive underscores the significance of having a well-organized and comprehensive data room, a critical asset in navigating the complexities of financial transactions and strategic decision-making. In the financial landscape, OGAdvisors recognizes that preparation is the linchpin of success. A well-prepared data room is a repository of accurate, up-to-date information crucial for due diligence processes, mergers and acquisitions, fundraising, and other financial transactions. OGAdvisors emphasizes the importance of anticipating future needs by encouraging clients to establish and maintain a robust data room well in advance of any potential financial endeavors. OGAdvisors assists clients in creating data rooms that are not only compliant with industry standards but go above and beyond, presenting information in a clear, organized, and easily accessible manner. This preparation not only expedites the decision-making process but also enhances the overall efficiency of financial transactions.

What do Kobe Bryant, Denzel Washington and Simon Sinek have in common? These leaders credit consistency as a top characteristic for success, accomplishment and fulfilling their dreams. Unfortunately, as a lifesciences executive, you can't be consistent all the time, everywhere. You are pulled in many different directions: 📖 Pulling your data together requires consistent experimentation 📊 Creating data visuals requires consistent reporting ⚖️ Working on your IP strategy requires consistent filing 👫 Personnel issues require consistent attention 💵 Consistent grant writing is critical to non-dilutive funding ...and business development requires consistency. Following through on emails, remembering to add requested materials to the data room, responding to licensee's questions in a timely fasion... Early in my career, as a CEO, I once lost a major deal because I wasn't consistent with my communications, and lost momentum with an important investor. Too many things pulled me in too many directions. At OGAdvisors, we use relationship databases, project management tools and constant collaboration with our clients and within our team to make sure opportunities are moving forward consistently. Our "fractional CBO" model allows you to focus on your science, your engineering, and growing your business, while we drive forward your transaction opportunities. So, if you can't manage to be consistent in communications with investors and partners without sacrificing the growth of your operations, consider giving us a call! The notion that "All That Matters Is Consistency" stands as a guiding principle for OGAdvisors, encapsulating the core philosophy that underpins their approach to business, personal growth, and client relationships. At OGAdvisors, consistency is not merely a routine but a commitment to excellence and reliability in every endeavor. In the realm of business, OGAdvisors believes that consistent, high-quality performance is the key to building trust and fostering enduring partnerships. Whether navigating complex financial landscapes, providing strategic advice, or implementing innovative solutions, the company's dedication to maintaining unwavering standards sets them apart.

It seems everyone is out to cure cancer, or have a $500k a year rare disease drug, and that's great - but there are times where your big story will only cause eyes to roll - so how will you know when to swing for the fences, and when to shoot for a single? The key is to understand if potential investors have experience in your specific disease or problem area, and in particular, if they have had bad experience. If things didn't turn out they way they wanted, they may still be very bullish on the segment, but they will be very, very clear eyed about the challenges - probably even more than you - if anyone tried to develop a non-invasive glucose sensor before, or an anti-angio-genesis drug, they will be very, very careful about jumping on the next opportunity, regardless of how big the market is. In these cases, it is better to shoot for a single - describe your data, toxicity, and aim for a sub-segment of the population that could be small, but is ideal for your solution. Lifesciences Dealmaking 601: Module 3: Compelling Solutions: Swing 4 The Fences or Shoot 4 a Single?

Forget the elevator pitch - in todays world of data overload, we may have as little as ten seconds to hook an investor, licensee, or potential acquirer to say "tell me more". So if you met your ideal partner at a networking event, do you know the best benefit to lead with? The beauty of our healthcare industry is that our molecules and technologies have so many benefits, both clinically and economically. We extend life and lessen suffering while reducing costs, minimizing hospitalizations, and improving provider margins. But...how do we know what to lead with? Large partners usually have no more than one priority that overarches all others for any specific segment. If you only have ten seconds to pitch to this partner, how would you determine how to align their priorities with all of the benefits of your technology? In this week's video, I discuss the process and benefits of proper positioning. The first step we at OGAdvisors take in new engagements is a positioning exercise, where we align the benefits of the technology with the motivations of potential partners. This is critical, as it sets the tone for months of outreach to follow. If you'd like to test whether your positioning is ideal, I encourage you to book a complimentary positioning call through our website ogadvisors.us it is both a valuable and fun exercise! #biotech #businessmodel #example #lifesciences #fundraising

Uploaded August 9th, 2023. In the early stages of a company's growth, scientific founders possess a significant advantage in guiding the business and in forming partnerships. I am lucky to be surrounded and mentored by scientific founders who taught me one crucial rule, that cultivated confidence among investors and partners, and assured them that they are the ideal leader for the company.

Have you ever spoken to a potential licensee or acquirer who asked for "More Data" than you currently have? How did you respond? Did it tempt you to alter your development plan according to their preferences? Or did you promise to reconnect once you gathered the additional data? From my experience, a request for "more" is often a stalling strategy. The potential partner is reluctant to commit, yet doesn't want to sever ties either. Would offering more data compel them to invest, license, or acquire your technology? Possibly, but it might also merely serve as a way for them to delay a decision further. To counter this, the very first step we at OGAdvisors take in a new engagement is to position the client's technology to be solving a pressing problem for the potential partner, instilling a sense of scarcity and urgency, which often nudges them towards action. In this short clip, I describe how at Edwards Lifesciences we pounced on a technology that deftly positioned itself as solving a problem for us. Ready to position your technology? Let's talk. Visit us at www.ogadvisors.us for a complementary discovery call. We're eager to assist you with a productive positioning exercise! Lifesciences Dealmaking 601: Module 4: Negotiations: 📈 What to do when they ask you for More Data

My clients are are sometimes surprised when news about signing a new marquee "beta" customer for their new healthtech or med device technology doesn't solicit the immediate market excitement they expected. Perhaps they expected it will lead to immediate conversions of current prospects into paying customers Or that it would generate investment enthusiasm Truth is - in many cases partnering with a marquee health system can reap significant benefits in the long-term - generating white papers, increasing market awareness and improving your technology, but the short-term benefits may not be as visible... When I work with a client on commercial partnerships, we therefore aim to balance between gaining marquee "betas" and and securing large health system clients that can generate and demonstrate short-term revenues. Lifesciences Dealmaking 601: Module 1: Fundraising practices: What they think of your Beta Customers